Abstract 2496: In silico screeening of therapeutics candidates targeting minimal residual disease in glioblastoma
Publication
, Conference
Congivaram, H; Tripathi, S; Gomez, M; McCortney, K; Wai, CM; Du, R; Sears, TK; Brat, DJ; Horbinski, CM; Youngblood, MW; Ahrendsen, JT; Sita, T ...
Published in: Cancer Research
April 3, 2026
Duke Scholars
Published In
Cancer Research
DOI
EISSN
1538-7445
ISSN
0008-5472
Publication Date
April 3, 2026
Volume
86
Issue
7_Supplement
Start / End Page
2496 / 2496
Publisher
American Association for Cancer Research (AACR)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Congivaram, H., Tripathi, S., Gomez, M., McCortney, K., Wai, C. M., Du, R., … Heimberger, A. B. (2026). Abstract 2496:
In silico
screeening of therapeutics candidates targeting minimal residual disease in glioblastoma. In Cancer Research (Vol. 86, pp. 2496–2496). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2026-2496
Congivaram, Harrshavasan, Shashwat Tripathi, Mateo Gomez, Katy McCortney, Ching Man Wai, Ruochen Du, Thomas K. Sears, et al. “Abstract 2496:
In silico
screeening of therapeutics candidates targeting minimal residual disease in glioblastoma.” In Cancer Research, 86:2496–2496. American Association for Cancer Research (AACR), 2026. https://doi.org/10.1158/1538-7445.am2026-2496.
Congivaram H, Tripathi S, Gomez M, McCortney K, Wai CM, Du R, et al. Abstract 2496:
In silico
screeening of therapeutics candidates targeting minimal residual disease in glioblastoma. In: Cancer Research. American Association for Cancer Research (AACR); 2026. p. 2496–2496.
Congivaram, Harrshavasan, et al. “Abstract 2496:
In silico
screeening of therapeutics candidates targeting minimal residual disease in glioblastoma.” Cancer Research, vol. 86, no. 7_Supplement, American Association for Cancer Research (AACR), 2026, pp. 2496–2496. Crossref, doi:10.1158/1538-7445.am2026-2496.
Congivaram H, Tripathi S, Gomez M, McCortney K, Wai CM, Du R, Sears TK, Brat DJ, Horbinski CM, Youngblood MW, Ahrendsen JT, Sonabend AM, Magill ST, Tate MC, Lesniak MS, Sachdev S, Sita T, Kumthekar P, Dixit K, Buerki R, Primdahl D, Khasraw M, de Groot J, Reardon DA, Lukas RV, Stupp R, Heimberger AB. Abstract 2496:
In silico
screeening of therapeutics candidates targeting minimal residual disease in glioblastoma. Cancer Research. American Association for Cancer Research (AACR); 2026. p. 2496–2496.
Published In
Cancer Research
DOI
EISSN
1538-7445
ISSN
0008-5472
Publication Date
April 3, 2026
Volume
86
Issue
7_Supplement
Start / End Page
2496 / 2496
Publisher
American Association for Cancer Research (AACR)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology